Needham upgraded Doximity from Hold to Buy and set a new price target of $38.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/20/2024 | $55.00 | Equal-Weight | Stephens |
| 12/4/2024 | $55.00 | Neutral | Mizuho |
| 11/15/2024 | $58.00 | Neutral | Goldman |
| 11/14/2024 | $33.00 → $53.00 | Underweight → Equal-Weight | Morgan Stanley |
| 11/13/2024 | $40.00 → $60.00 | Buy → Hold | Canaccord Genuity |
| 11/8/2024 | $19.00 → $41.00 | Underweight → Equal Weight | Wells Fargo |
| 11/8/2024 | $70.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 10/15/2024 | $35.00 → $52.00 | Equal Weight → Overweight | Barclays |
4 - Doximity, Inc. (0001516513) (Issuer)
4 - Doximity, Inc. (0001516513) (Issuer)
4 - Doximity, Inc. (0001516513) (Issuer)
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu
Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to help physicians save time, so they can provide better care for their patients." Fiscal 2025 Second Quarter Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2023. Revenue:
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members includ
Stephens initiated coverage of Doximity with a rating of Equal-Weight and set a new price target of $55.00
Mizuho initiated coverage of Doximity with a rating of Neutral and set a new price target of $55.00
Goldman initiated coverage of Doximity with a rating of Neutral and set a new price target of $58.00
SC 13G/A - Doximity, Inc. (0001516513) (Subject)
SC 13G - Doximity, Inc. (0001516513) (Subject)
SC 13G - Doximity, Inc. (0001516513) (Subject)
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu
Physicians report telemedicine boosts access, contributes to better disease management, and improves patient outcomes Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine's value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to or, depending on the patient, a replacement for in-person care. As part of the study, Doximity analyzed the ad
Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to help physicians save time, so they can provide better care for their patients." Fiscal 2025 Second Quarter Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2023. Revenue:
10-Q - Doximity, Inc. (0001516513) (Filer)
8-K - Doximity, Inc. (0001516513) (Filer)
SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati
Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one